24th February 2020
BCUHB Executive Medical Director Dr David Fearnley said:
“Significant investment in additional staff and resources, including the development of a new £2.3m hybrid theatre, means we now have a stable, fit-for-purpose, modern vascular service.
“Under the previous service model, patients who live in rural locations in Anglesey and Gwynedd had to travel to Wrexham for emergency vascular surgery for half of the week.
“It is widely recognised that the previous service model was too stretched and did not meet national guidelines. Without changing the service, we would not have been able to recruit doctors in the future, meaning we would lose the service in North Wales altogether.
“We have recruited seven vascular consultants since moving forward with the change in service, and now have a sustainable on-call rota which can care for patients in need of emergency care."
From 10 April 2019, Glan Clwyd Hospital will become the arterial centre for the vascular network and will provide all emergency and elective arterial surgery and complex endovascular interventions. In order to support this the Health Board has appointed clinical staff, opened an additional ring fenced arterial ward and installed a state of the art hybrid operating theatre.
The 24-hour-a-day, 7-days-a-week consultant vascular emergency rota will run from Glan Clwyd Hospital. It currently runs from Ysbyty Gwynedd and Wrexham Maelor Hospital on an alternating basis. In simple terms, at present for half of the week emergency care is available in Wrexham, and for half of the week it’s based in Bangor. By locating the small number of emergency cases in one site, it means everyone has equal access to the best expertise, regardless of where in North Wales they live.
The acute hospitals; Wrexham Maelor Hospital, Glan Clwyd Hospital and Ysbyty Gwynedd will continue to have a consultant surgeon presence and will provide the following clinical services: vascular clinics, diagnostics, interventions including renal access and varicose vein procedures, review of in-patient vascular referrals, and rehabilitation. Day-case peripheral angioplasty and simple stenting will also continue at all sites.
Why is this service changing?
Are renal services moving?
Media reports have made reference to dangers if patients are not seen in “the golden hour”
Who has supported the decision the board made in January 2013?